James E. Flynn - Director, * Director by Deputization, 10%+ Owner at Larimar Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, * Director by Deputization, 10%+ Owner
Issuer Symbol
LRMR on Nasdaq
All Insider Reports
All Insider Reports

James E. Flynn - trading volume in the past year for Larimar Therapeutics, Inc.

Holdings reported by James E. Flynn for Larimar Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 10,622,957 $53,114,785 $5.00 27 Feb 2026 Through Deerfield Private Design Fund IV, L.P.
Common Stock 10,622,928 $53,114,640 $5.00 27 Feb 2026 Through Deerfield Private Design Fund III, L.P.
Common Stock 8,153,107 $40,765,535 $5.00 27 Feb 2026 Through Deerfield Healthcare Innovations Fund, L.P.
Common Stock 6,207,982 $31,039,910 $5.00 27 Feb 2026 Through Deerfield Partners, L.P.
Stock Option (Right to Buy) 19,000 13 May 2025 Through Deerfield Management Company, L.P. Common Stock

Transactions reported by James E. Flynn for Larimar Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.